Corporate ManufacturerCached Profile
NOVARTIS PHARMACEUTICALS CORPORATION
Manufacturer Corporate ID: 100000000228
Subsidiaries Logged: 1 entities
LIFETIME CORPORATE SPEND
$10,083,389
General Payments Aggregated (2021–2025)
Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
Top Funded Physicians
Physicians receiving the highest promotional payments from this corporation.
1. Dr. SZILARD VOROSMedical Doctor
$1,990,4802. Dr. JOHN CUSHMedical Doctor
$674,4953. Dr. GRAHAM WALKERMedical Doctor
$308,7074. Dr. JOSEPH HABBOUSHEMedical Doctor
$308,7075. Dr. KRISTEN PALLOKMedical Doctor
$207,791Top Promoted Products
Drugs or medical devices receiving the highest marketing backing.
1. COSENTYX$1,380,114 (13.7%)
2. KESIMPTA$293,612 (2.9%)
3. ILARIS$289,462 (2.9%)
4. XOLAIR$244,466 (2.4%)
5. RHAPSIDO$242,900 (2.4%)
Active Subsidiary Entities
Corporate subsidiaries and brands associated with this manufacturer ID in Open Payments.
NOVARTIS PHARMACEUTICALS CORPORATION
Corporate General Payouts Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2025
2025
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for NOVARTIS PHARMACEUTICALS CORPORATION...